Form 4: Dolby Laboratories Director Emily Rollins Executes Stock Sale

Director Emily Rollins sold 1,000 shares of Dolby Laboratories Class A common stock on January 30, 2025, at a price of $84.9 per share.

Summary

• Emily Rollins, a director at Dolby Laboratories, sold 1,000 shares of Class A common stock on January 30, 2025.
• The sale was executed at a price of $84.9 per share.
• Following the transaction, Ms. Rollins beneficially owns 6,493 shares of Class A common stock.
• This includes 2,952 shares underlying restricted stock units that vest on the date of this Form 4.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a stock sale by a director, with no inherent positive or negative sentiment.

Industry Context

This is a routine disclosure of a stock transaction by a company director, which is common practice for publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with those requirements.
• Similar filings are made by directors and officers of companies like Apple, Microsoft, and Google when they trade their company's stock.

Stakeholder Impact

• The stock sale by a director may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial position.

Key Dates

Keywords

Dolby Laboratories, Emily Rollins, stock sale, Class A common stock, director, insider trading, Form 4